Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.073 AUD | 0.00% | -2.67% | +5.80% |
04-17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
04-17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
- Stock Market
- Equities
- NTI Stock
- Charts Neurotech International Limited
- Total Return chart